Laurie Alsup
Director/Board Member presso BLACKBERRY LIMITED
Patrimonio netto: 652 647 $ in data 31/03/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| John Houston | M | 64 |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | 7 anni |
| Timothy Shannon | M | 65 |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | 11 anni |
| Jakob Loven | M | 46 |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | 3 anni |
| Dean Mitchell | M | 68 | 10 anni | |
| Sean Cassidy | M | 54 |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | 11 anni |
| Richard Lynch | M | 76 | 11 anni | |
| Randy Teel | M | 45 | 6 anni | |
| Bradley Margus | M | 63 |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | 10 anni |
| Steve Rai | M | - | - | |
| Liam Ratcliffe | M | 60 |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | 9 anni |
| Briggs Morrison | M | 65 |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | 6 anni |
| Dennis Ryan | M | 69 | 1 anni | |
| Leslie Norwalk | F | 58 |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | 5 anni |
| John Giamatteo | M | 57 | - | |
| Rhonda Farnum | F | 59 | 6 anni | |
| Wayne Wouters | M | 73 | 9 anni | |
| Jared M. Freedberg | M | 55 | - | |
| Ian Taylor | M | 61 | 8 anni | |
| Jeremy Grant | M | 36 | 1 anni | |
| Lars-Helge Stromquist | M | 75 |
NDA Group AB
 NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | 27 anni |
| Tim Foote | M | - | - | |
| Richard Graham | M | - | - | |
| Brett Grimaud | M | 50 | 3 anni | |
| John Grosso | M | - | - | |
| Aziz Sawaf | M | 42 | 10 anni | |
| Aine Miller | M | 47 | - | |
| Lisa Disbrow | F | 61 | 5 anni | |
| Linda Bain | F | 53 | 4 anni | |
| Eran Broshy | M | 65 | 10 anni | |
| Burt Malkiel | M | 90 | 11 anni | |
| Deepa Pakianathan | M | 59 | 4 anni | |
| Michael Daniels | M | 78 | 10 anni | |
| Wendy Dixon | M | 68 | 4 anni | |
| Susannah Gray | F | 63 | 1 anni | |
| Rick Winningham | M | 64 | 11 anni | |
| Jim Kelly | M | 43 | 1 anni | |
| John Young | M | 60 | 2 anni | |
| Phil Kurtz | M | - | - | |
| Donal O'Connor | M | 73 | 9 anni | |
| Edward Kennedy | M | 62 | 6 anni | |
| Everett Cunningham | M | 57 | 2 anni | |
| Stuart Knight | M | - | 10 anni | |
| Philip Brace | M | 53 | - | |
| Jesse Harold | M | - | 16 anni | |
| Stacy Pryce | F | - | - | |
| Kimberly Wehger | F | - | - | |
| Marjorie Dickman | F | - | 4 anni | |
| Neelam Sandhu | F | - | - | |
| Kirsten Owens | F | - | - | |
| Mattias Eriksson | M | - | - | |
| Tim Power | M | - | 18 anni | |
| Charles Eagan | M | - | 6 anni | |
| Steve Weiss | M | 55 | 6 anni | |
| Sunil Agarwal | M | 54 | 1 anni | |
| Arvind Raman | M | - | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Mark Meltz | M | 50 | 4 anni | |
| Peter R. Dolan | M | 68 | 18 anni | |
| Uri Lopatin | M | 52 | 3 anni | |
| James Cornelius | M | 81 | 10 anni | |
| Stephen W. Kaldor | M | 62 | 3 anni | |
| Mark Auerbach | M | 85 | 2 anni | |
| Randall Cook | M | - | - | |
| Nima Farzan | M | 48 | 4 anni | |
| Ilya Raskin | M | - |
Phytomedics, Inc.
 Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Phytomedics, Inc. discovers, develops, and manufactures botanical therapeutics using proprietary platform technologies. The company was founded in December 1996 by Ilya Raskin and is headquartered in Jamesburg, NJ. | 16 anni |
| David W. Pritchard | M | 69 | 8 anni | |
| Herbert Cross | M | 52 | 2 anni | |
| Ted Love | M | 65 | 6 anni | |
| James Healy | M | 58 | 13 anni | |
| Barbara Stymiest | F | 67 | 15 anni | |
| Ronald Martell | M | 62 |
Kalobios Pharmaceuticals, Inc.
| - |
| Steven Capelli | M | 67 | - | |
| Eric Murphy | M | 48 | 3 anni | |
| Vicki Sato | M | 75 | 15 anni | |
| Martin Shkreli | M | 41 | - | |
| Bob Petrou | M | 52 | 16 anni | |
| Peter S. Ringrose | M | 78 | 7 anni | |
| John Tsai | M | 57 | 11 anni | |
| Louis J. Freeh | M | 74 | 8 anni | |
| Donald Joseph | M | 70 | 2 anni | |
| Robert Williams | M | 75 | 7 anni | |
| Mark Wilson | M | - | 10 anni | |
| Renée Galá | F | 52 | 5 anni | |
| Douglas Manion | M | 64 | 11 anni | |
| Timothy Dattels | M | 66 | 11 anni | |
| Joe L. del Callar | M | - | - | |
| David J. Helfgott | M | - | - | |
| William Young | M | 79 | 10 anni | |
| Dennis J. Henner | M | 72 | 8 anni | |
| Michael Grobstein | M | 81 | 13 anni | |
| Louis Gerstner | M | - | - | |
| Susan Molineaux | M | 70 | 7 anni | |
| George M. Whitesides | M | 84 | 8 anni | |
| Robert Gunderson | M | 72 | 8 anni | |
| Bradford J. Shafer | M | 63 | 7 anni | |
| Raymond M. Withy | M | 68 | 10 anni | |
| Prem Watsa | M | 74 | 11 anni | |
| John Chen | M | 68 | 10 anni | |
| Gary Lyons | M | 73 | 4 anni | |
| Gerald Bruce | M | 68 | 8 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 74 | 74.75% |
| Canada | 24 | 24.24% |
| Svezia | 1 | 1.01% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Laurie Alsup
- Contatti personali
